APA (7th ed.) Citation

K, A. R., A, J., A, A. B., A, A. B., R, R., & S, U. (2026). Super Responder of 177 Lu-PSMA-617 PSMA Therapy in Patient With End-Stage Renal Disease on Hemodialysis. Clinical nuclear medicine, 51(4), e276. https://doi.org/10.1097/RLU.0000000000006112

Chicago Style (17th ed.) Citation

K, Al Riyami, Jain A, Al Busaidi A, Al Balushi A, Rasheed R, and Usmani S. "Super Responder of 177 Lu-PSMA-617 PSMA Therapy in Patient With End-Stage Renal Disease on Hemodialysis." Clinical Nuclear Medicine 51, no. 4 (2026): e276. https://doi.org/10.1097/RLU.0000000000006112.

MLA (9th ed.) Citation

K, Al Riyami, et al. "Super Responder of 177 Lu-PSMA-617 PSMA Therapy in Patient With End-Stage Renal Disease on Hemodialysis." Clinical Nuclear Medicine, vol. 51, no. 4, 2026, p. e276, https://doi.org/10.1097/RLU.0000000000006112.